Pharmaceutical Executive September 2, 2024
Mike Hollan

The insurance company is offering the guidance in response to continued popularity of the drugs which are commonly used for weight-loss management.

Over the past two years, GLP-1s have become one of the most popular medications in the United States. Due to medications’ impact on appetite and eating habits, they’ve become very popular weight loss drugs for many people who struggling with obesity. As such, demand for the drugs has increased, which has caused insurance companies to develop strategies on how to help their customers obtain these medications while also ensure that they are doing so in a healthy way.

Personify Health, a healthcare insurance provider, recently shared best practices for GLP-1s for employers who utilize Personify’s services.1 These practices...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Employer, Insurance, Pharma / Biotech
The Pandemic Proved That Remote Leadership Works
More than 65 Organizations Call on Workplaces to Provide Comprehensive Obesity Care Coverage
The state of AI: How organizations are rewiring to capture value
To reduce healthcare costs, address chronic conditions
Why Leaders Must Rethink Customer Experience Amid Continued AI Investment

Share This Article